|
IL137665A0
(en)
*
|
1998-07-17 |
2001-10-31 |
Janssen Pharmaceutica Nv |
Pellets having core coated with an antifungal and a polymer
|
|
ES2157731B1
(es)
|
1998-07-21 |
2002-05-01 |
Liconsa Liberacion Controlada |
Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
|
|
DK1163234T3
(da)
|
1999-03-24 |
2006-02-27 |
Scherer Technologies Inc R P |
Farmaceutiske formuleringer med forbedret vandoplöselighed
|
|
KR100432949B1
(ko)
*
|
2000-06-13 |
2004-05-31 |
코오롱제약주식회사 |
생체이용율이 향상된 이트라코나졸의 분립체 조성물과이를 이용한 이트라코나졸 제제 및 그 제조방법
|
|
US6663897B2
(en)
*
|
2001-02-06 |
2003-12-16 |
Dsm Ip Assets B.V. |
Oral itraconazole formulations and methods of making the same
|
|
SK287582B6
(sk)
|
2001-02-14 |
2011-03-04 |
Tibotec Pharmaceuticals Ltd. |
2-(Substituovaná amino)benztiazolsulfonamidová zlúčenina, spôsob jej prípravy, použitie a farmaceutická zmes s jej obsahom
|
|
WO2002081478A2
(en)
|
2001-04-09 |
2002-10-17 |
Tibotec Pharmaceuticals Ltd. |
Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
|
|
BR0209594A
(pt)
|
2001-05-11 |
2004-03-30 |
Tibotec Pharm Ltd |
Inibidores de protease de hiv de amplo espectro de 2-amino-benzoxazol sulfonamida
|
|
WO2002100407A1
(en)
*
|
2001-06-12 |
2002-12-19 |
Smartrix Technologies Inc. |
Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
|
|
US8071133B2
(en)
|
2001-08-20 |
2011-12-06 |
Stiefel Laboratories, Inc. |
Oral dosage forms of water insoluble drugs and methods of making the same
|
|
HRP20040662B1
(hr)
|
2001-12-21 |
2013-12-06 |
Tibotec Pharmaceuticals Ltd. |
Sulfonamidi koji sadrže heterociklički supstituirani fenil kao inhibitori hiv proteaze širokog spektra
|
|
MY142238A
(en)
|
2002-03-12 |
2010-11-15 |
Tibotec Pharm Ltd |
Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
|
|
SI1517899T1
(sl)
|
2002-05-17 |
2008-02-29 |
Tibotec Pharm Ltd |
Substituirani benzoksazol sulfonamidi sirokega spektra, ki so HIV proteazni inhibitorji
|
|
BR0305771A
(pt)
|
2002-08-14 |
2004-10-05 |
Tibotec Pharm Ltd |
Inibidores de protease do hiv oxindol sulfonamida substituìdos de amplo espectro
|
|
KR100557680B1
(ko)
*
|
2002-11-23 |
2006-03-07 |
한국유나이티드제약 주식회사 |
이트라코나졸의 용해도 개선을 위한 펠렛제제 및 그제조방법
|
|
SI1438960T2
(sl)
*
|
2003-01-14 |
2013-04-30 |
Cimex Pharma Ag |
Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljšano biorazpoložljivostjo
|
|
DE60312636T3
(de)
*
|
2003-01-14 |
2014-12-24 |
Acino Pharma Ag |
Bioaequivalente Zusammensetzung in der Form einer festen Dispersion enthaltend Itraconazol und ein hydrophiles Polymer
|
|
NZ545145A
(en)
*
|
2003-08-06 |
2009-07-31 |
Nirmal Mulye |
Pharmaceutical composition containing water soluble drug
|
|
CN1849117B
(zh)
|
2003-09-11 |
2010-05-26 |
泰博特克药品有限公司 |
Hiv病毒的侵入抑制剂
|
|
EP1568369A1
(en)
|
2004-02-23 |
2005-08-31 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of meloxicam for the treatment of respiratory diseases in pigs
|
|
AR048650A1
(es)
|
2004-05-04 |
2006-05-10 |
Tibotec Pharm Ltd |
Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
|
|
AU2005244121B2
(en)
|
2004-05-07 |
2012-01-19 |
Sequoia Pharmaceuticals, Inc. |
Resistance-repellent retroviral protease inhibitors
|
|
US7622582B2
(en)
|
2004-05-17 |
2009-11-24 |
Tibotec Bvba |
Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one
|
|
TW200607502A
(en)
|
2004-05-17 |
2006-03-01 |
Tibotec Pharm Ltd |
6, 7, 8, 9-substituted 1-phenyl-1, 5-dihydro-pyrido[3, 2-b]indol-2-ones
|
|
MXPA06013314A
(es)
|
2004-05-17 |
2007-02-02 |
Tibotec Pharm Ltd |
1-heterociclil-1,5-dihidro-pirido[3,2-b]indol-2-onas.
|
|
WO2007113290A1
(en)
|
2006-04-03 |
2007-10-11 |
Tibotec Pharmaceuticals Ltd. |
Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
|
|
BRPI0716481A2
(pt)
*
|
2006-09-04 |
2014-03-18 |
Panacea Biotec Ltd |
Tecnologia de liberação flutuante programável
|
|
KR100809903B1
(ko)
*
|
2006-09-05 |
2008-03-06 |
주식회사유한양행 |
안정화된 클로피도그렐-함유 입자, 그의 제조방법, 및 이를포함하는 약학 조성물
|
|
CN101283984B
(zh)
*
|
2007-04-12 |
2010-05-26 |
永胜药品工业股份有限公司 |
高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
|
|
JP2008280254A
(ja)
*
|
2007-05-08 |
2008-11-20 |
Everest Pharm Industrial Co Ltd |
生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
|
|
US8313527B2
(en)
|
2007-11-05 |
2012-11-20 |
Allergan, Inc. |
Soft prosthesis shell texturing method
|
|
CN101965186A
(zh)
|
2007-11-28 |
2011-02-02 |
塞阔伊亚药品公司 |
抑制细胞色素p450 2d6的化合物和方法
|
|
CA2716348C
(en)
|
2008-02-21 |
2017-04-04 |
Sequoia Pharmaceuticals, Inc. |
Diamide inhibitors of cytochrome p450
|
|
US9050184B2
(en)
|
2008-08-13 |
2015-06-09 |
Allergan, Inc. |
Dual plane breast implant
|
|
US8877822B2
(en)
|
2010-09-28 |
2014-11-04 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
|
US9205577B2
(en)
|
2010-02-05 |
2015-12-08 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
|
US9138309B2
(en)
|
2010-02-05 |
2015-09-22 |
Allergan, Inc. |
Porous materials, methods of making and uses
|
|
SG174658A1
(en)
|
2010-04-01 |
2011-10-28 |
Theravida Inc |
Pharmaceutical formulations for the treatment of overactive bladder
|
|
US11202853B2
(en)
|
2010-05-11 |
2021-12-21 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
|
EP2569021B1
(en)
*
|
2010-05-11 |
2017-01-04 |
Allergan, Inc. |
Porogen compositions, methods of making and uses
|
|
US8679279B2
(en)
|
2010-11-16 |
2014-03-25 |
Allergan, Inc. |
Methods for creating foam-like texture
|
|
CN102100678B
(zh)
*
|
2011-02-18 |
2012-10-17 |
天津力生制药股份有限公司 |
伊曲康唑硫酸盐微丸及其制备方法
|
|
CA2895083A1
(en)
|
2012-12-13 |
2014-06-19 |
Allergan, Inc. |
Device and method for making a variable surface breast implant
|
|
US10092392B2
(en)
|
2014-05-16 |
2018-10-09 |
Allergan, Inc. |
Textured breast implant and methods of making same
|
|
WO2017127073A1
(en)
*
|
2016-01-20 |
2017-07-27 |
Theravida, Inc. |
Methods and compositions for treating hyperhidrosis
|
|
DK3781132T3
(da)
*
|
2018-04-16 |
2024-04-22 |
Bristol Myers Squibb Co |
Apixabanformuleringer
|
|
CN114767636B
(zh)
*
|
2022-04-11 |
2023-11-07 |
苏州中化药品工业有限公司 |
伊曲康唑微丸、制备方法及伊曲康唑微丸胶囊
|